Statistics

Total Visits

Views
Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study 95

Total Visits Per Month

April 2025 May 2025 June 2025 July 2025 August 2025 September 2025 October 2025
Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study 2 0 0 1 0 12 3

File Visits

Views
SCOPUS2079701X-2021-20-SID85123097278-a1.pdf 5

Top country views

Views
Russia 35

Top cities views

Views
Kazan 35

Search DSpace


Advanced Search

Browse

My Account

Statistics